Literature DB >> 27917751

HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.

Q Y Chen1, X Y Wang1, T J Harrison2, X He3, L P Hu1, K W Li1, H H Jia1, Q L Yang1, C Wang1, Z L Fang1.   

Abstract

HBsAg reappearance may constitute not only a risk for liver disease but also an infectious source. We aimed to determine whether HBsAg may reappear after spontaneous HBsAg seroclearance. A cohort of 2999 HBsAg-positive subjects aged 30-55 years was recruited in Guangxi, China in 2004. HBsAg was tested every 6 months from July 2004 to June 2007, then, one more time in December 2013. The results showed that spontaneous HBsAg seroclearance occurred in 41 subjects in the first 3 years, giving a 0·54% annual seroclearance rate. Thirteen of the 41 subjects were randomly tested for HBsAg in 2013. Four subjects became HBsAg positive. S gene sequences of HBV were analysed from serum collected before seroclearance and after reappearance, respectively, for subject QS840 (11 and 12 clones), subject TN98 (13 and 13 clones) and subject WX227 (10 and 8 clones). Serotype, subgenotype and amino-acid substitution pattern in each sample collected after reappearance was observed in the sample collected before HBsAg seroclearance. Nucleotide similarity between the two sequences from each subject was >99% and five sequences from subject TN98 were the same. In conclusion, following reactivation, HBsAg may reappear in individuals with spontaneous HBsAg seroclearance many years previously.

Entities:  

Keywords:  Genotypes; HBsAg; hepatitis B virus (HBV); mutations; reappearance; seroclearance; serotype

Mesh:

Substances:

Year:  2016        PMID: 27917751      PMCID: PMC9507753          DOI: 10.1017/S095026881600279X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  31 in total

1.  Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.

Authors:  Matsuo Deguchi; Naoko Yamashita; Masanori Kagita; Seishi Asari; Yoshinori Iwatani; Takahiko Tsuchida; Kazushige Iinuma; Isa K Mushahwar
Journal:  J Virol Methods       Date:  2004-02       Impact factor: 2.014

2.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

3.  Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance.

Authors:  Eugenia Lauret; María L González-Diéguez; Mercedes Rodríguez; Marta González; Santiago Melón; Luis Rodrigo; Manuel Rodríguez
Journal:  Liver Int       Date:  2014-01-24       Impact factor: 5.828

4.  Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.

Authors:  Sandro C Ferreira; Silvana G F Chachá; Fernanda F Souza; Andreza C Teixeira; Rodrigo C Santana; Márcia G Villanova; Sérgio Zucoloto; Leandra N Ramalho; Gleici S C Perdoná; Afonso D C Passos; Ana L C Martinelli
Journal:  Ann Hepatol       Date:  2014 Nov-Dec       Impact factor: 2.400

5.  HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection.

Authors:  Zhen-Ge Han; Zhong-Hong Qie; Wei-Zhen Qiao
Journal:  J Med Virol       Date:  2016-01       Impact factor: 2.327

6.  A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.

Authors:  Jessica Liu; Mei-Hsuan Lee; Richard Batrla-Utermann; Chin-Lan Jen; Uchenna H Iloeje; Sheng-Nan Lu; Li-Yu Wang; San-Lin You; Chuhsing K Hsiao; Hwai-I Yang; Chien-Jen Chen
Journal:  J Hepatol       Date:  2012-12-13       Impact factor: 25.083

7.  Hepatitis B virus reactivation or reinfection associated with HIV-1 infection.

Authors:  J Waite; R J Gilson; I V Weller; C J Lacey; M H Hambling; A Hawkins; M Briggs; R S Tedder
Journal:  AIDS       Date:  1988-12       Impact factor: 4.177

8.  A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

Authors:  J P Villeneuve; M Desrochers; C Infante-Rivard; B Willems; G Raymond; M Bourcier; J Côté; G Richer
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

9.  Reactivation of hepatitis B virus in HBsAg-negative patients with hepatocellular carcinoma.

Authors:  Jeong Won Jang; Young Woon Kim; Sung Won Lee; Jung Hyun Kwon; Soon Woo Nam; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Kyu Won Chung
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

10.  Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

Authors:  Robert Perrillo; Maria Buti; Francois Durand; Michael Charlton; Adrian Gadano; Guido Cantisani; Che-Chuan Loong; Kimberly Brown; Wenhua Hu; Juan Carlos Lopez-Talavera; Cyril Llamoso
Journal:  Liver Transpl       Date:  2013-08       Impact factor: 5.799

View more
  2 in total

1.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

Review 2.  Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Rev Med Virol       Date:  2018-05-15       Impact factor: 6.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.